Literature DB >> 11799917

Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.

D Medina1, H Thompson, H Ganther, C Ip.   

Abstract

Selenium compounds have attracted renewed interest as chemopreventive agents for human cancer on the basis of the pioneering intervention study by Clark and co-workers. The rodent mammary gland has been used extensively as a model for examining the chemopreventive activities of inorganic and organic selenium compounds. This review summarizes the rationale and results for use of a new organic selenium compound, Se-methylselenocysteine, which exhibits greater efficacy as a chemopreventive agent than several previously used selenium compounds in experimental models of breast cancer and has potential for use in human populations.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11799917     DOI： 10.1207/S15327914NC401_5

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN： 0163-5581            Impact factor:   2.900


  32 in total

Review 1.  Selenoproteins that function in cancer prevention and promotion.

Authors:  Dolph L Hatfield; Min-Hyuk Yoo; Bradley A Carlson; Vadim N Gladyshev
Journal:  Biochim Biophys Acta       Date:  2009-03-09

2.  Imbalance in Protein Thiol Redox Regulation and Cancer-Preventive Efficacy of Selenium.

Authors:  Rayudu Gopalakrishna; Usha Gundimeda; Sarah Zhou; Kristen Zung; Kaitlyn Forell; Arne Holmgren
Journal:  React Oxyg Species (Apex)       Date:  2016-05-25

3.  Activation of FOXO1 is critical for the anticancer effect of methylseleninic acid in prostate cancer cells.

Authors:  Haitao Zhang; Jian Fang; Dian Yao; Yue Wu; Clement Ip; Yan Dong
Journal:  Prostate       Date:  2010-09-01       Impact factor: 4.104

4.  The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells.

Authors:  Rami G Azrak; Cheryl L Frank; Xiang Ling; Harry K Slocum; Fengzhi Li; Barbara A Foster; Youcef M Rustum
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

5.  Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis.

Authors:  Tamaro S Hudson; Bradley A Carlson; Mark J Hoeneroff; Heather A Young; Lorraine Sordillo; William J Muller; Dolph L Hatfield; Jeffrey E Green
Journal:  Carcinogenesis       Date:  2012-03-20       Impact factor: 4.944

6.  Methylselenocysteine resets the rhythmic expression of circadian and growth-regulatory genes disrupted by nitrosomethylurea in vivo.

Authors:  Ming Zhu Fang; Xun Zhang; Helmut Zarbl
Journal:  Cancer Prev Res (Phila)       Date:  2010-04-27

7.  Induction of cytokine gene expression in human thyroid epithelial cells irradiated with HZE particles (iron ions).

Authors:  Jenine K Sanzari; Manunya Nuth; Ann R Kennedy
Journal:  Radiat Res       Date:  2009-10       Impact factor: 2.841

8.  Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.

Authors:  Brian L Lindshield; Nikki A Ford; Kirstie Canene-Adams; Alan M Diamond; Matthew A Wallig; John W Erdman
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

9.  Influence of Alternative Tubulin Inhibitors on the Potency of a Epirubicin-Immunochemotherapeutic Synthesized with an Ultra Violet Light-Activated Intermediate: Influence of incorporating an internal/integral disulfide bond structure and Alternative Tubulin/Microtubule Inhibitors on the Cytotoxic Anti-Neoplastic Potency of Epirubicin-(C3-amide)-Anti-HER2/neu Synthesized Utilizing a UV-Photoactivated Anthracycline Intermediate.

Authors:  C P Coyne; Toni Jones; Ryan Bear
Journal:  Cancer Clin Oncol       Date:  2012-11

10.  Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells.

Authors:  Rizky Abdulah; Ahmad Faried; Kenji Kobayashi; Chiho Yamazaki; Eka W Suradji; Kazuto Ito; Kazuhiro Suzuki; Masami Murakami; Hiroyuki Kuwano; Hiroshi Koyama
Journal:  BMC Cancer       Date:  2009-11-30       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.